Abstract 22
Introduction 48
Influenza, a highly contagious group of RNA viruses of the family Orthomyxoviridae, is 49 one of the most important causes of seasonal respiratory illness worldwide. The majority of 50 infected patients resolve influenza infection without difficulty. However, a subset of patients 51 suffers from severe disease or mortality. In the United States, influenza-related mortality can 52 reach nearly 50,000 deaths in some seasons (1). In addition to the burden posed by seasonal 53 influenza epidemics, the potential for catastrophic pandemic influenza A is a constant threat. 54
Despite the availability of influenza vaccines, sub-optimal vaccine efficacy, uptake, and strain 55 matching makes influenza infection an ongoing public health problem. 56
The association between influenza A virus (IAV) infection and secondary bacterial 57 pneumonia, particularly during pandemic disease, is now well established. During the 1918 58 Spanish influenza pandemic, nearly all influenza-associated deaths were associated with 59 evidence of bacterial super-infection, predominantly with upper respiratory tract bacterial 60 pathogens (32). In recent years, an increasing role for bacterial super-infections as a cause of 61 influenza-associated mortality during seasonal influenza epidemics, particularly due to 62 community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), has been 63 appreciated (14, 18, 36) . Therefore, increasing focus has been paid towards understanding the 64 established methods as previously described (13, 26) . Epithelial cells were dissociated and 145 seeded onto collagen-coated, semipermeable membranes with a 0.4-µm pore size 146 surface area, 0.6 cm 2 ; EMD Millipore, Billerica, MA). Cells were maintained in 2% Ultroser G 147 medium at 37 °C with 5% CO 2 . Twenty-four hours after seeding, the mucosal medium was 148 removed and the cells were allowed to grow at the air-liquid interface. Only well-differentiated 149 cultures (>4 weeks old) were used in these studies. The presence of tight junctions between 150 differentiated epithelial cells was confirmed by trans-epithelial resistance using an electrical 151 resistance system (ERS) meter (EMD Millipore; resistance >500 Ω·cm 2 ). Cells were stimulated 152 for 24 hours with IL-17A (10 ng/ml) and/or TNF-α (1 ng/ml) (R&D Systems, Minneapolis, MN). 153
Gene expression was analyzed by TaqMan-based RT-PCR (ABI7700, Applied Biosystems, 154
Foster City, CA) using the ΔΔCT method relative to the endogenous control gene 155 β−glucuronidase for the target BPIFA1, formerly known as PLUNC or SPLUNC1 (7). Human 156 lipocalin 2 (LCN2) was assessed utilizing Assay on Demand Taqman primer and probe sets 157 (Applied Biosystems, Foster City, CA), relative to the endogenous control gene β−actin. BPIFA1 158 concentration was measured in HBE cell culture supernatant following 24 hours of stimulation 159 with cytokine by ELISA (Hycult Biotech, Plymouth Meeting, PA). In the mouse model, lung 160 expression of mouse BPIFA1 and LCN2 was measured as described above. 161
162
Statistical analyses -All data are presented as mean ± standard error of the mean. Significance 163 was determined by unpaired t-test or one-way ANOVA followed by post-hoc Tukey test for 164 multiple comparisons, as appropriate. A P value < 0.05 was considered to be statistically 165 significant. Data were processed using the Microsoft Excel and GraphPad Prism (GraphPad 166 Software Inc., La Jolla, CA) software packages. 167
Results

169
To examine the effects of IAV on Type 17 immune responses during subsequent 170 infection with Gram-negative bacteria, mice were challenged with influenza A/PR/8/34 or vehicle 171 for six days prior to challenge with E. coli or vehicle. Twenty-four hours later, tissues were 172 harvested and bacterial burden and inflammation were assessed. Preceding IAV significantly 173 increased E. coli burden in the lung and resulted in increased BAL neutrophil counts compared 174 to single pathogen-challenged mice ( Figure 1A, B) . Furthermore, coinfection resulted in 175 significantly increased levels of the granulocyte promoting cytokines IL-6, G-CSF, KC, and MIP-176 1α compared to either challenge alone ( Figure 1C ). Similar to data found with S. aureus 177 coinfection, IAV significantly attenuated subsequent IL-1β production in response to E. coli 178 ( Figure 1D ). TNF-α was significantly increased by coinfection, while IFN-γ production was 179 significantly increased during influenza and during coinfection compared to bacterial infection 180 alone. Coinfected mice also had evidence of greater lung damage compared to mice infected 181 with bacteria alone, with increased LDH (mean OD 490 1.3 vs 0.28, p<0.0001, data not shown) 182 and total protein as measured by BCA assay (mean, 3999 vs 592.2 μg/mL, p<0.0001, data not 183 shown). These data show that E. coli burden is increased during IAV coinfection despite 184 elevated innate immune cell recruitment to the lung and that coinfected mice have greater lung 185 damage than mice with bacterial pneumonia alone. 186
The initial findings in the IAV, E. coli coinfection model were thus similar to those 187 reported with S. aureus (23). We next examined if Type 17 immune activation by E. coli was 188 suppressed by preceding IAV infection. IL-17 and IL-22 expression were markedly induced by 189 E. coli challenge and this production was significantly attenuated by preceding IAV (Figure 2A To confirm that host responses were similar in the context of other bacterial infections, we challenged mice with influenza A/PR/8/34 or vehicle for six days prior to 197 challenge with P. aeruginosa, an important, clinically relevant opportunistic human respiratory 198 pathogen. We again observed significant exacerbation of lung bacterial burden in coinfected 199 mice ( Figure 3A) , which was associated with increased BAL neutrophil counts ( Figure 3B We previously demonstrated that AMP expression was attenuated in IAV, S. aureus 214 coinfection compared to S. aureus infection alone (35). To see if similar effects could be 215 observed with Gram-negative infection, we examined expression of AMPs with known activity 216 against Gram-negative bacteria. First, we confirmed in vitro that IL-17 acts synergistically with 217 TNF-α to augment expression of both BPIFA1 ( Figure 4A ) and LCN2 ( Figure 4B ) as well as to 218 stimulate the secretion of BPIF1A ( Figure 4C ) in HBE cells. In vivo, E. coli significantly induced 219 BPIFA1 expression, which was inhibited by preceding IAV infection ( Figure 4D ), while LCN2 220 expression was unchanged (data not shown). P. aeruginosa significantly induced both BPIFA1 221 and LCN2 expression, which were both inhibited by preceding IAV infection ( Figure 4E) . These 222 findings demonstrate that IL-17 is required for optimal induction of BPIFA1 and LCN2, but that 223 preceding IAV attenuates production of these AMPs by Gram-negative bacteria. 224
We have previously implicated type I IFN signaling in the exacerbation of secondary S. 225 aureus infection following IAV (23). Since we observed increased type I IFN production in IAV, 226 E. coli co-infected mice, we investigated the role of type I IFN in susceptibility to bacterial 227 infection. WT or IFNAR-/-mice were challenged with influenza A/PR/8/34 or vehicle for six days 228 prior to challenge with E. coli or vehicle for one additional day. IAV failed to significantly 229 exacerbate E. coli bacterial burden in the lung in IFNAR-/-mice ( Figure 5A ). Neutrophils in the 230 BAL were significantly increased in co-infected WT mice compared to single-pathogen infection 231 and were similarly increased in IFNAR-/-mice ( Figure 5B ). IFN-γ and TNF-α production did not 232 differ between WT and IFNAR-/-mice ( Figure 5C ). IL-1β production was significantly 233 suppressed during coinfection in WT mice compared to E. coli alone, but was similar in co-234 infected and E. coli infected IFNAR-/-mice. Finally, IL-17 gene expression was clearly elevated 235 in IFNAR-/-mice compared to WT during influenza and coinfection, although these results did 236 not reach statistical significance, while WT mice showed significant attenuation of IL-17 237 expression during coinfection compared to E. coli alone ( Figure 5D ). These data suggest that 238 type I IFN is important in the exacerbation of IL-6, KC, IFN-γ, TNF-α, IP-10, MIP-1α, MIP-2, and G-CSF were decreased in coinfection 257 compared to S. aureus infection alone. These data indicate that IAV no longer attenuated S. 258 aureus clearance when challenged fourteen days after infection and that coinfection resulted in 259 decreased lung cytokine production at this time point compared to bacterial infection alone. 260
Since bacterial clearance was not affected by IAV fourteen days after challenge, we 261 examined activation of Type 17 immunity at this time. S. aureus induced similar expression of 262 IL-17 and ROR-γt in S. aureus and coinfected animals ( Figure 7A ). IL-17 protein production was 263 not different between S. aureus and coinfected mice ( Figure 7B ). However, production of IL- 22 264 and IL-23 were statistically lower in coinfected mice compared to S. aureus alone ( Figure 7C ). 265
These data indicate that Type 17 immunity may only be partially functional during coinfection at 266 this later time point. Finally, we examined IFN-β and IFN-γ production in the lung during the IAV 267 infection time course. IFN-β levels peaked at day four post infection and remained elevated 268 through day ten ( Figure 7D ). By day fourteen after IAV infection, IFN-β expression was similar to 269 sham treated mice. IFN-γ protein levels were highest on day six post-infection and were not 270 significantly elevated at any other time point ( Figure 7E ). These data suggest that the lack of 271 type I IFN at fourteen days post-influenza may explain the lack of exacerbation of S. aureus 272 clearance.
Discussion 274
These data demonstrate that preceding IAV infection impairs the host response to 275 bacterial challenge with Gram-negative bacteria, similar to the attenuation previously described 276 during IAV and Gram-positive bacterial coinfection (23, 25) . Importantly, bacterial challenge in 277 the setting of elevated type I IFN expression (i.e. during a specific window period during 278 influenza infection) was associated with attenuation of Type 17 immunity in WT, but not IFNAR 279 -/-mice. To our knowledge these are the first data that demonstrate attenuation of Type 17 280 immunity against Gram-negative bacteria in the setting of IAV infection. These findings support 281 previously reported data suggesting the importance of type I IFN in the subversion of Type 17 282 immunity, increasing host susceptibility to infection from a broad range of extracellular bacteria, 283 including bacterial coinfections complicating influenza. 284
In this study, the major effect of preceding influenza infection on bacterial infection was 285 delayed clearance from the lung, as lethality was not assessed and neither E. coli nor P. 286 aeruginosa exhibited increases in bacterial burden beyond the infecting inoculum that would 287 suggest uncontrolled or overwhelming infection. A previous study showed similar delays in 288 bacterial clearance in the context of influenza and K. pneumoniae coinfection, which was also 289 associated with increased subsequent mortality (20) . We previously demonstrated that bacterial 290 clearance from the lung during influenza, S. aureus coinfection was significantly delayed 291 compared to bacterial infection alone (35). In our current study, coinfection was associated with 292 significantly increased inflammation and evidence of increased lung injury compared to bacterial 293 infection alone, suggesting that delayed clearance might expose the host to a prolonged 294 duration of inflammation and associated risk of greater lung injury. Similar to our previous 295 findings, increased neutrophils and inflammatory cytokines and chemokines were observed in 296 coinfected mice, suggesting that impaired bacterial clearance was not due to a defect in 297 inflammatory cell recruitment to the lung (23, 34). Furthermore, neutrophil depletion has not 298 been shown to affect S. aureus lung bacterial burden, suggesting an alternate mechanism for 299 impaired bacterial clearance (22, 35) . This is in contrast to reports of neutrophil-dependent 300 mechanisms during IAV, Streptococcus pneumoniae coinfection (31, 38). In one study, 301 decreased levels of KC and MIP-2 were observed in coinfection and exogenous KC and MIP-2 302 rescued bacterial clearance, but restoration of neutrophil recruitment was not explicitly 303 demonstrated (38). Furthermore, no attenuation of KC or MIP-2 was observed in our model. It is 304 possible that species-specific bacterial effects may play some role, with differences in the 305 murine response to S. pneumoniae and S. aureus. 306
As expected, infection with E. coli or P. aeruginosa alone was associated with increased 307 IL-23, ROR-α, and ROR-γt, consistent with Type 17 immune activation. In E. coli infection alone, 308 increased protein levels of IL-1β and IL-17A and increased expression of IL-17A and IL-22 were 309 also detected. These responses were attenuated in mice infected with IAV alone and in 310 coinfected mice, consistent with IAV-associated inhibition of Type 17 activity. As no defects in 311 inflammatory cell recruitment were observed despite suppressed Type 17 activity, we sought to 312 determine if AMP production was attenuated (35). In vitro, IL-17 alone was not sufficient for 313 AMP expression, but IL-17 in the context of low levels of TNF-α clearly augmented AMP 314 expression by HBE. In vivo, expression of BPIFA1 and LCN2 were suppressed during IAV, P. 315 aeruginosa coinfection, with similar results seen for BPIFA1 during IAV, E. coli coinfection. 316
Importantly, AMP expression in vivo did not appear to be modulated solely by TNF-α, which was 317 significantly elevated in IAV, E. coli coinfection but was not detected at this time point in IAV, P. 318 aeruginosa coinfection. BPIFA1 is secreted by secretory cells of the airway epithelium, and in 319 mice has been shown to contribute to lung defense against Gram-negative bacteria, mainly due 320 to inhibition of biofilm formation (6, 12, (26) (27) (28) 37) . To our knowledge, this is the first assessment 321 of the role of BPIFA1 in response to E. coli pneumonia in vivo. The role of LCN2 in mucosal 322 defense against both Gram-positive and Gram-negative bacteria is well established (3, 9, 15, 35, 44) , where LCN2 exerts bacteriostatic activity via interference of siderophore-mediated 324 bacterial iron acquisition (17). As neither BPIFA1 nor LCN2 are bactericidal, they alone are 325 unlikely to be sufficient effectors of antimicrobial killing. Rather, they likely reflect activation of 326 host responses that synergize to promote bacterial eradication. We have previously shown that 327 exogenous LCN2 rescued the bacterial clearance defect in IAV, S. aureus coinfection, 328 demonstrating the importance of AMP production in bacterial clearance, despite lack of direct 329 bactericidal activity ( Numerous studies have demonstrated that increased susceptibility to secondary 382 bacterial pneumonia due to S. aureus or S. pneumoniae began following elevations in type I IFN 383 production, typically three to seven days following IAV infection, while IFNAR-/-were rescued 384 from impaired bacterial clearance or mortality (23-25, 30, 31, 34, 35, 38-40) . Goldman M, Jansen HM, Lutter R, and van der Poll T. IL-10 is an important mediator of the 550 enhanced susceptibility to pneumococcal pneumonia after influenza infection. C  2d  4d  6d  8d  10d  12d 14d † E
